{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:23:06Z","timestamp":1765610586335,"version":"3.44.0"},"posted":{"date-parts":[[2025,8,25]]},"group-title":"In Review","reference-count":81,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,8,8]]},"abstract":"<title>Abstract<\/title>\n        <p><italic>Background<\/italic>: Sepsis (life-threatening organ dysfunction caused by a dysregulated host response to infection) causes millions of deaths worldwide annually. Sepsis-induced changes in brain regulatory functions remain understudied.  Previous work demonstrated that cecal ligation and puncture (CLP, a murine model of sepsis) affected physiologic variables and serum cytokines and hormone levels.  Correction of decreased activity in the orexinergic nervous system or administration of the M1 muscarinic acetylcholine receptor (M1mAChR) agonist xanomeline reversed some of these findings.   We hypothesized that these <bold>CLP - induced changes resulted, in part, from a loss of M1mAChR-mediated orexinergic nervous system activation<\/bold>.   \n<italic>Main Body<\/italic>: Xanomeline reversed CLP-induced loss of orexinergic activity and restored physiologic variables and hormone levels to baseline; these corrections were eliminated by addition of the orexin receptor antagonist almorexant.  To examine the effects of system reactivation we developed a transgenic mouse whose orexinergic neurons could be depolarized via a Designer Receptor Exclusively Activated by Designer Drugs (DREADD) and its ligand, clozapine-N-oxide (CNO).  Orexinergic re-activation or xanomeline administration reversed CLP-induced changes in TNFa and IL-1b levels; almorexant eliminated xanomeline effects.  CNO reversed the effects of CLP on serum levels of IL-6 and KC; this effect was not present after xanomeline administration.  G-CSF, a colony stimulating factor, was not affected by either CNO or xanomeline.  Both orexinergic activation and xanomeline administration reversed CLP-induced increase in the number of splenic macrophages and monocyte-derived dendritic cells (DCs); almorexant did not affect the response to xanomeline.  CLP-induced decreases in the numbers of central DCs, CD4<sup>+<\/sup> or CD8<sup>+<\/sup> T cell numbers in the spleen; this response was not altered by either CNO or xanomeline. \n<italic>Conclusion<\/italic>: Decreased orexinergic activity mediates some post-CLP immunologic changes, identifying a previously unrecognized proximal pathogenic mechanism in sepsis.  Some, but not all, of these changes result from a loss of M1mAChR-mediated stimulation of orexinergic neurons.  These findings suggests that disruption of orexin\u2019s central coordinating function is a key, and perhaps causative, component of the dysregulated host response that is the defining characteristic of sepsis.<\/p>","DOI":"10.21203\/rs.3.rs-7329263\/v1","type":"posted-content","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T12:44:41Z","timestamp":1756125881000},"source":"Crossref","is-referenced-by-count":1,"title":["Loss of M1 Acetylcholine Receptor-mediated Orexinergic Activity Contributes to Immune Dysfunction in Experimental Sepsis"],"prefix":"10.21203","author":[{"given":"Ana","family":"Nedeljkovic-Kurepa","sequence":"first","affiliation":[{"name":"Northwell Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mabel N.","family":"Abraham","sequence":"additional","affiliation":[{"name":"Northwell Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiago D.","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Northwell Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar","family":"Yaipen","sequence":"additional","affiliation":[{"name":"Northwell Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana R.","family":"Brewer","sequence":"additional","affiliation":[{"name":"Northwell Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew D.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Northwell Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin A.","family":"Pavlov","sequence":"additional","affiliation":[{"name":"Northwell Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clifford S.","family":"Deutschman","sequence":"additional","affiliation":[{"name":"Northwell Health"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"8","key":"ref1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer M","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"10219","key":"ref2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd KE","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200\u201311.","journal-title":"Lancet"},{"issue":"7","key":"ref3","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/00003246-199607000-00008","article-title":"Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome","volume":"24","author":"Godin PJ","year":"1996","unstructured":"Godin PJ, Buchman TG. Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome. Crit Care Med. 1996;24(7):1107\u201316.","journal-title":"Crit Care Med"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13613-024-01377-0","article-title":"Organ crosstalk and dysfunction in sepsis","volume":"14","author":"Borges A","year":"2024","unstructured":"Borges A, Bento L. Organ crosstalk and dysfunction in sepsis. Ann Intens Care. 2024;14(1):147.","journal-title":"Ann Intens Care"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ccc.2017.08.006","article-title":"Endocrine and metabolic alterations in sepsis and implications for treatment","volume":"34","author":"Ingels C","year":"2018","unstructured":"Ingels C, Gunst J, Van den Berghe G. Endocrine and metabolic alterations in sepsis and implications for treatment. Crit Care Clin. 2018;34:81\u201396.","journal-title":"Crit Care Clin"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1097\/CCM.0b013e31828e9843","article-title":"Orexinergic activity modulates altered vital signs and pituitary hormone secretion in experimental sepsis","volume":"41","author":"Deutschman CS","year":"2013","unstructured":"Deutschman CS, Raj NR, McGuire EO, Kelz MB. Orexinergic activity modulates altered vital signs and pituitary hormone secretion in experimental sepsis. Crit Care Med. 2013;41(11):e368\u2013375.","journal-title":"Crit Care Med"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1055\/s-0044-1787554","article-title":"Dysregulation of Host-Pathogen Interactions in Sepsis: Host-Related Factors","volume":"45","author":"Joosten SCM","year":"2024","unstructured":"Joosten SCM, Wiersinga WJ, Poll TV. Dysregulation of Host-Pathogen Interactions in Sepsis: Host-Related Factors. Sem Respiratory Crit Care Med. 2024;45(4):469\u201378.","journal-title":"Sem Respiratory Crit Care Med"},{"issue":"12","key":"ref8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1159\/000509353","article-title":"Acute Cardiorenal Syndrome: Models and Heart-Kidney Connectors","volume":"144","author":"Funahashi Y","year":"2020","unstructured":"Funahashi Y, Chowdhury S, Eiwaz MB, Hutchens MP. Acute Cardiorenal Syndrome: Models and Heart-Kidney Connectors. Nephron. 2020;144(12):629\u201333.","journal-title":"Nephron"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.semnephrol.2011.11.010","article-title":"The role of inflammation in the cardio-renal syndrome: a focus on cytokines and inflammatory mediators","volume":"32","author":"Rosner MH","year":"2012","unstructured":"Rosner MH, Ronco C, Okusa MD. The role of inflammation in the cardio-renal syndrome: a focus on cytokines and inflammatory mediators. Semin Nephrol. 2012;32(1):70\u20138.","journal-title":"Semin Nephrol"},{"issue":"10","key":"ref10","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1161\/CIRCRESAHA.122.319989","article-title":"Cardiorenal Syndrome: The Role of Neural Connections Between the Heart and the Kidneys","volume":"130","author":"Patel KP","year":"2022","unstructured":"Patel KP, Katsurada K, Zheng H. Cardiorenal Syndrome: The Role of Neural Connections Between the Heart and the Kidneys. Circ Res. 2022;130(10):1601\u201317.","journal-title":"Circ Res"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nn.4477","article-title":"Neural regulation of immunity: molecular mechanisms and clinical translation","volume":"20","author":"Pavlov VA","year":"2017","unstructured":"Pavlov VA, Tracey KJ. Neural regulation of immunity: molecular mechanisms and clinical translation. Nat Neurosci. 2017;20(2):156\u201366.","journal-title":"Nat Neurosci"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrendo.2012.189","article-title":"The vagus nerve and the inflammatory reflex\u2013linking immunity and metabolism","volume":"8","author":"Pavlov VA","year":"2012","unstructured":"Pavlov VA, Tracey KJ. The vagus nerve and the inflammatory reflex\u2013linking immunity and metabolism. Nat reviews Endocrinol. 2012;8(12):743\u201354.","journal-title":"Nat reviews Endocrinol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.bbi.2014.07.010","article-title":"Xanomeline suppresses excessive pro-inflammatory cytokine responses through neural signal-mediated pathways and improves survival in lethal inflammation","volume":"44","author":"Rosas-Ballina M","year":"2015","unstructured":"Rosas-Ballina M, Valdes-Ferrer SI, Dancho ME, Ochani M, Katz D, Cheng KF, et al. Xanomeline suppresses excessive pro-inflammatory cytokine responses through neural signal-mediated pathways and improves survival in lethal inflammation. Brain Behav Immun. 2015;44:19\u201327.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s10020-024-00787-x","article-title":"M1 cholinergic signaling in the brain modulates cytokine levels and splenic cell sub-phenotypes following cecal ligation and puncture","volume":"30","author":"Abraham MN","year":"2024","unstructured":"Abraham MN, Nedeljkovic-Kurepa A, Fernandes TD, Yaipen O, Brewer MR, Leisman DE, et al. M1 cholinergic signaling in the brain modulates cytokine levels and splenic cell sub-phenotypes following cecal ligation and puncture. Mol Med. 2024;30(1):22.","journal-title":"Mol Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e13902","DOI":"10.1111\/jsr.13902","article-title":"The orexin story and orexin receptor antagonists for the treatment of insomnia","author":"Muehlan C","year":"2023","unstructured":"Muehlan C, Roch C, Vaillant C, Dingemanse J. The orexin story and orexin receptor antagonists for the treatment of insomnia. J Sleep Res. 2023:e13902.","journal-title":"J Sleep Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejphar.2017.11.004","article-title":"Cardiovascular pressor effects of orexins in the dorsomedial hypothalamus","volume":"818","author":"Li TL","year":"2018","unstructured":"Li TL, Chen JYS, Huang SC, Dai YE, Hwang LL. Cardiovascular pressor effects of orexins in the dorsomedial hypothalamus. Eur J Pharmacol. 2018;818:343\u201350.","journal-title":"Eur J Pharmacol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.autneu.2016.08.012","article-title":"Blockade of orexin receptors attenuates the cardiovascular response to air-jet stress in spontaneously hypertensive rats","volume":"201","author":"Martin EJ","year":"2016","unstructured":"Martin EJ, Hernandez ME, Hayward LF. Blockade of orexin receptors attenuates the cardiovascular response to air-jet stress in spontaneously hypertensive rats. Auton Neurosci. 2016;201:8\u201316.","journal-title":"Auton Neurosci"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuropharm.2012.10.021","article-title":"Orexin A regulates cardiovascular responses in stress-induced hypertensive rats","volume":"67","author":"Xiao F","year":"2013","unstructured":"Xiao F, Jiang M, Du D, Xia C, Wang J, Cao Y, et al. Orexin A regulates cardiovascular responses in stress-induced hypertensive rats. Neuropharmacol. 2013;67:16\u201324.","journal-title":"Neuropharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.resp.2014.06.006","article-title":"Orexin induces excitation of respiratory neuronal network in isolated brainstem spinal cord of neonatal rat","volume":"200","author":"Sugita T","year":"2014","unstructured":"Sugita T, Sakuraba S, Kaku Y, Yoshida K, Arisaka H, Kuwana S. Orexin induces excitation of respiratory neuronal network in isolated brainstem spinal cord of neonatal rat. Respir Physiol Neurobiol. 2014;200:105\u20139.","journal-title":"Respir Physiol Neurobiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1017\/S1462399408000823","article-title":"Hypothalamic orexins\/hypocretins as regulators of breathing","volume":"10","author":"Williams RH","year":"2008","unstructured":"Williams RH, Burdakov D. Hypothalamic orexins\/hypocretins as regulators of breathing. Expert Rev Mol Med. 2008;10:e28.","journal-title":"Expert Rev Mol Med"},{"issue":"25","key":"ref21","doi-asserted-by":"crossref","first-page":"10685","DOI":"10.1073\/pnas.0702676104","article-title":"Control of hypothalamic orexin neurons by acid and CO2","volume":"104","author":"Williams RH","year":"2007","unstructured":"Williams RH, Jensen LT, Verkhratsky A, Fugger L, Burdakov D. Control of hypothalamic orexin neurons by acid and CO2. Proc Natl Acad Sci U S A. 2007;104(25):10685\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.bbr.2011.01.047","article-title":"The lateral hypothalamus: a site for integration of nutrient and fluid balance","volume":"221","author":"Dijk G","year":"2011","unstructured":"van Dijk G, Evers SS, Guidotti S, Thornton SN, Scheurink AJ, Nyakas C. The lateral hypothalamus: a site for integration of nutrient and fluid balance. Behav Brain Res. 2011;221(2):481\u20137.","journal-title":"Behav Brain Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"101066","DOI":"10.1016\/j.yfrne.2023.101066","article-title":"Targeting the orexin\/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies","volume":"69","author":"Ten-Blanco M","year":"2023","unstructured":"Ten-Blanco M, Flores A, Cristino L, Pereda-Perez I, Berrendero F. Targeting the orexin\/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies. Front Neuroendocrinol. 2023;69:101066.","journal-title":"Front Neuroendocrinol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"136247","DOI":"10.1016\/j.neulet.2021.136247","article-title":"The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target","volume":"765","author":"Gao F","year":"2021","unstructured":"Gao F, Liu T, Tuo M, Chi S. The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target. Neurosci Lett. 2021;765:136247.","journal-title":"Neurosci Lett"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"104882","DOI":"10.1016\/j.neuint.2020.104882","article-title":"Bidirectional gut-brain communication: A role for orexin-A","volume":"141","author":"Mediavilla C","year":"2020","unstructured":"Mediavilla C. Bidirectional gut-brain communication: A role for orexin-A. Neurochem Int. 2020;141:104882.","journal-title":"Neurochem Int"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3389\/fendo.2019.00830","article-title":"Key Regulators of Energy Homeostasis","volume":"10","author":"Milbank E","year":"2019","unstructured":"Milbank E, Lopez M, Orexins\/Hypocretins. Key Regulators of Energy Homeostasis. Front Endocrinol (Lausanne). 2019;10:830.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3389\/fncir.2016.00066","article-title":"Role of the Orexin System on the Hypothalamus-Pituitary-Thyroid Axis","volume":"10","author":"Messina A","year":"2016","unstructured":"Messina A, De Fusco C, Monda V, Esposito M, Moscatelli F, Valenzano A, et al. Role of the Orexin System on the Hypothalamus-Pituitary-Thyroid Axis. Front Neural Circuits. 2016;10:66.","journal-title":"Front Neural Circuits"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/cne.21131","article-title":"Innervation of orexin\/hypocretin neurons by GABAergic, glutamatergic or cholinergic basal forebrain terminals evidenced by immunostaining for presynaptic vesicular transporter and postsynaptic scaffolding proteins","volume":"499","author":"Henny P","year":"2006","unstructured":"Henny P, Jones BE. Innervation of orexin\/hypocretin neurons by GABAergic, glutamatergic or cholinergic basal forebrain terminals evidenced by immunostaining for presynaptic vesicular transporter and postsynaptic scaffolding proteins. J Comp Neurol. 2006;499(4):645\u201361.","journal-title":"J Comp Neurol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fnbeh.2017.00010","article-title":"Basal Forebrain Cholinergic System and Orexin Neurons: Effects on Attention","volume":"11","author":"Villano I","year":"2017","unstructured":"Villano I, Messina A, Valenzano A, Moscatelli F, Esposito T, Monda V, et al. Basal Forebrain Cholinergic System and Orexin Neurons: Effects on Attention. Front Behav Neurosci. 2017;11:10.","journal-title":"Front Behav Neurosci"},{"issue":"7","key":"ref30","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/cne.24158","article-title":"Descending projections from the basal forebrain to the orexin neurons in mice","volume":"525","author":"Agostinelli LJ","year":"2017","unstructured":"Agostinelli LJ, Ferrari LL, Mahoney CE, Mochizuki T, Lowell BB, Arrigoni E, et al. Descending projections from the basal forebrain to the orexin neurons in mice. J Comp Neurol. 2017;525(7):1668\u201384.","journal-title":"J Comp Neurol"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1748-1716.2009.02036.x","article-title":"Activation of the basal forebrain by the orexin\/hypocretin neurones","volume":"198","author":"Arrigoni E","year":"2010","unstructured":"Arrigoni E, Mochizuki T, Scammell TE. Activation of the basal forebrain by the orexin\/hypocretin neurones. Acta Physiol (Oxf). 2010;198(3):223\u201335.","journal-title":"Acta Physiol (Oxf)"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3389\/fimmu.2019.00585","article-title":"Forebrain Cholinergic Signaling Regulates Innate Immune Responses and Inflammation","volume":"10","author":"Lehner KR","year":"2019","unstructured":"Lehner KR, Silverman HA, Addorisio ME, Roy A, Al-Onaizi MA, Levine Y, et al. Forebrain Cholinergic Signaling Regulates Innate Immune Responses and Inflammation. Front Immunol. 2019;10:585.","journal-title":"Front Immunol"},{"issue":"10","key":"ref33","doi-asserted-by":"crossref","first-page":"e1075","DOI":"10.1097\/CCM.0000000000002646","article-title":"Selective Activation of Basal Forebrain Cholinergic Neurons Attenuates Polymicrobial Sepsis-Induced Inflammation via the Cholinergic Anti-Inflammatory Pathway","volume":"45","author":"Zhai Q","year":"2017","unstructured":"Zhai Q, Lai D, Cui P, Zhou R, Chen Q, Hou J, et al. Selective Activation of Basal Forebrain Cholinergic Neurons Attenuates Polymicrobial Sepsis-Induced Inflammation via the Cholinergic Anti-Inflammatory Pathway. Crit Care Med. 2017;45(10):e1075\u201382.","journal-title":"Crit Care Med"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbi.2008.06.011","article-title":"Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway","volume":"23","author":"Pavlov VA","year":"2009","unstructured":"Pavlov VA, Parrish WR, Rosas-Ballina M, Ochani M, Puerta M, Ochani K, et al. Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav Immun. 2009;23(1):41\u20135.","journal-title":"Brain Behav Immun"},{"issue":"10","key":"ref35","doi-asserted-by":"crossref","first-page":"e109272","DOI":"10.1371\/journal.pone.0109272","article-title":"Central muscarinic cholinergic activation alters interaction between splenic dendritic cell and CD4\u2009+\u2009CD25- T cells in experimental colitis","volume":"9","author":"Munyaka P","year":"2014","unstructured":"Munyaka P, Rabbi MF, Pavlov VA, Tracey KJ, Khafipour E, Ghia JE. Central muscarinic cholinergic activation alters interaction between splenic dendritic cell and CD4\u2009+\u2009CD25- T cells in experimental colitis. PLoS ONE. 2014;9(10):e109272.","journal-title":"PLoS ONE"},{"issue":"7\u20138","key":"ref36","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2119\/molmed.2011.00083","article-title":"Galantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice","volume":"17","author":"Satapathy SK","year":"2011","unstructured":"Satapathy SK, Ochani M, Dancho M, Hudson LK, Rosas-Ballina M, Valdes-Ferrer SI, et al. Galantamine alleviates inflammation and other obesity-associated complications in high-fat diet-fed mice. Mol Med. 2011;17(7\u20138):599\u2013606.","journal-title":"Mol Med"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41590-023-01660-5","article-title":"The pathophysiology of sepsis and precision-medicine-based immunotherapy","volume":"25","author":"Giamarellos-Bourboulis EJ","year":"2024","unstructured":"Giamarellos-Bourboulis EJ, Aschenbrenner AC, Bauer M, Bock C, Calandra T, Gat-Viks I, et al. The pathophysiology of sepsis and precision-medicine-based immunotherapy. Nat Immunol. 2024;25(1):19\u201328.","journal-title":"Nat Immunol"},{"issue":"11","key":"ref38","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1042\/CS20211003","article-title":"Novel insights in endocrine and metabolic pathways in sepsis and gaps for future research","volume":"136","author":"T\u00e9blick A","year":"2022","unstructured":"T\u00e9blick A, Gunst J, Langouche L, Van den Berghe G. Novel insights in endocrine and metabolic pathways in sepsis and gaps for future research. Clin Sci (Lond). 2022;136(11):861\u201378.","journal-title":"Clin Sci (Lond)"},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"EVIDra2200118","DOI":"10.1056\/EVIDra2200118","article-title":"Immune Modulation in Sepsis, ARDS, and Covid-19 - The Road Traveled and the Road Ahead","volume":"1","author":"Leligdowicz A","year":"2022","unstructured":"Leligdowicz A, Harhay MO, Calfee CS. Immune Modulation in Sepsis, ARDS, and Covid-19 - The Road Traveled and the Road Ahead. NEJM Evid. 2022;1(11):EVIDra2200118.","journal-title":"NEJM Evid"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3389\/fimmu.2020.01318","article-title":"Glucocorticoids in Sepsis: To Be or Not to Be","volume":"11","author":"Vandewalle J","year":"2020","unstructured":"Vandewalle J, Libert C. Glucocorticoids in Sepsis: To Be or Not to Be. Front Immunol. 2020;11:1318.","journal-title":"Front Immunol"},{"issue":"1","key":"ref41","doi-asserted-by":"crossref","first-page":"7473","DOI":"10.1038\/s41598-024-58075-x","article-title":"Control of breathing by orexinergic signaling in the nucleus tractus solitarii","volume":"14","author":"Wang Y","year":"2024","unstructured":"Wang Y, Deng T, Zhao X, Shao L, Chen J, Fu C, et al. Control of breathing by orexinergic signaling in the nucleus tractus solitarii. Sci Rep. 2024;14(1):7473.","journal-title":"Sci Rep"},{"issue":"6","key":"ref42","first-page":"e028987","article-title":"Attenuation of Hypocretin\/Orexin Signaling Is Associated With Increased Mortality After Myocardial Infarction","volume":"12","author":"Wohlfahrt P","year":"2023","unstructured":"Wohlfahrt P, Jen\u010da D, Melenovsk\u00fd V, Jarol\u00edm P, Dlouh\u00e1 D, \u0160ramko M, et al. Attenuation of Hypocretin\/Orexin Signaling Is Associated With Increased Mortality After Myocardial Infarction. JAMA. 2023;12(6):e028987.","journal-title":"JAMA"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1080\/10253890.2019.1621283","article-title":"Common pathways and communication between the brain and heart: connecting post-traumatic stress disorder and heart failure","volume":"22","author":"Wilson MA","year":"2019","unstructured":"Wilson MA, Israel L, LM L, Yana L, RV B, Renu S, et al. Common pathways and communication between the brain and heart: connecting post-traumatic stress disorder and heart failure. Stress. 2019;22(5):530\u201347.","journal-title":"Stress"},{"issue":"11","key":"ref44","doi-asserted-by":"crossref","first-page":"9554","DOI":"10.3390\/ijms24119554","article-title":"Efficiency of Orexin-A for Inflammatory Flare and Mucosal Healing in Experimental Colitis: Comparison with the Anti-TNF Alpha Infliximab","volume":"24","author":"Blais A","year":"2023","unstructured":"Blais A, Lan A, Blachier F, Benamouzig R, Jouet P, Couvineau A. Efficiency of Orexin-A for Inflammatory Flare and Mucosal Healing in Experimental Colitis: Comparison with the Anti-TNF Alpha Infliximab. Int J Molec Sci. 2023;24(11):9554.","journal-title":"Int J Molec Sci"},{"issue":"23","key":"ref45","doi-asserted-by":"crossref","first-page":"7196","DOI":"10.3390\/jcm11237196","article-title":"Protective Effects of Orexin A in a Murine Model of Cisplatin-Induced Acute Kidney Injury","volume":"11","author":"Jo J","year":"2022","unstructured":"Jo J, Kim J-Y, Leem J. Protective Effects of Orexin A in a Murine Model of Cisplatin-Induced Acute Kidney Injury. J Clin Med. 2022;11(23):7196.","journal-title":"J Clin Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nature01321","article-title":"The inflammatory reflex","volume":"420","author":"Tracey KJ","year":"2004","unstructured":"Tracey KJ. The inflammatory reflex. Nature. 2004;420:853\u20139.","journal-title":"Nature"},{"issue":"6","key":"ref47","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.pharep.2019.06.005","article-title":"Muscarinic M1 and M2 receptor subtypes play opposite roles in LPS-induced septic shock","volume":"71","author":"Wang Z","year":"2019","unstructured":"Wang Z, Li M, Liu L, Geng B. Muscarinic M1 and M2 receptor subtypes play opposite roles in LPS-induced septic shock. Pharmacol Rep. 2019;71(6):1108\u201314.","journal-title":"Pharmacol Rep"},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"166230","DOI":"10.1016\/j.bbadis.2021.166230","article-title":"Orexin-A alleviates astrocytic apoptosis and inflammation via inhibiting OX1R-mediated NF-\u03baB and MAPK signaling pathways in cerebral ischemia\/reperfusion injury","volume":"1867","author":"Xu D","year":"2021","unstructured":"Xu D, Kong T, Shao Z, Liu M, Zhang R, Zhang S, et al. Orexin-A alleviates astrocytic apoptosis and inflammation via inhibiting OX1R-mediated NF-\u03baB and MAPK signaling pathways in cerebral ischemia\/reperfusion injury. Biochim Biophys Acta Mol Basis Dis. 2021;1867(11):166230.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"11","key":"ref49","doi-asserted-by":"crossref","first-page":"e70096","DOI":"10.1111\/cns.70096","article-title":"Orexin-A Attenuates the Inflammatory Response in Sepsis-Associated Encephalopathy by Modulating Oxidative Stress and Inhibiting the ERK\/NF-\u03baB Signaling Pathway in Microglia and Astrocytes","volume":"30","author":"Guo J","year":"2024","unstructured":"Guo J, Kong D, Luo J, Xiong T, Wang F, Deng M, et al. Orexin-A Attenuates the Inflammatory Response in Sepsis-Associated Encephalopathy by Modulating Oxidative Stress and Inhibiting the ERK\/NF-\u03baB Signaling Pathway in Microglia and Astrocytes. CNS Neurosci Ther. 2024;30(11):e70096.","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"ref50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12974-024-03111-w","article-title":"Therapeutic effects of orexin-A in sepsis-associated encephalopathy in mice","volume":"21","author":"Guo J","year":"2024","unstructured":"Guo J, Kong Z, Yang S, Da J, Chu L, Han G, et al. Therapeutic effects of orexin-A in sepsis-associated encephalopathy in mice. J Neuroinflammation. 2024;21(1):131.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"ref51","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.intimp.2012.07.020","article-title":"Role of M3 mAChR in in vivo and in vitro models of LPS-induced inflammatory response","volume":"14","author":"Xu ZP","year":"2012","unstructured":"Xu ZP, Yang K, Xu GN, Zhu L, Hou LN, Zhang WH, et al. Role of M3 mAChR in in vivo and in vitro models of LPS-induced inflammatory response. Int Immunopharmacol. 2012;14(3):320\u20137.","journal-title":"Int Immunopharmacol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.3389\/fimmu.2017.01085","article-title":"Expression and Function of the Cholinergic System in Immune Cells","volume":"8","author":"Fujii T","year":"2017","unstructured":"Fujii T, Mashimo M, Moriwaki Y, Misawa H, Ono S, Horiguchi K, et al. Expression and Function of the Cholinergic System in Immune Cells. Front Immunol. 2017;8:1085.","journal-title":"Front Immunol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.biopha.2018.07.159","article-title":"Orexin A may suppress inflammatory response in fibroblast-like synoviocytes","volume":"107","author":"Sun M","year":"2018","unstructured":"Sun M, Wang W, Li Q, Yuan T, Weng W. Orexin A may suppress inflammatory response in fibroblast-like synoviocytes. Biomed Pharmacother. 2018;107:763\u20138.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"ref54","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1080\/21691401.2019.1614014","article-title":"Orexin A ameliorates HBV X protein-induced cytotoxicity and inflammatory response in human hepatocytes","volume":"47","author":"Wang L","year":"2019","unstructured":"Wang L, He T, Wan B, Wang X, Zhang L. Orexin A ameliorates HBV X protein-induced cytotoxicity and inflammatory response in human hepatocytes. Artif Cells Nanomed Biotechnol. 2019;47(1):2003\u20139.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"102458","DOI":"10.1016\/j.npep.2024.102458","article-title":"The protective effects of orexin B in neuropathic pain by suppressing inflammatory response","volume":"108","author":"Zhu Z","year":"2024","unstructured":"Zhu Z, Chen G, He J, Xu Y. The protective effects of orexin B in neuropathic pain by suppressing inflammatory response. Neuropeptides. 2024;108:102458.","journal-title":"Neuropeptides"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"177014","DOI":"10.1016\/j.ejphar.2024.177014","article-title":"Esketamine improves cognitive function in sepsis-associated encephalopathy by inhibiting microglia-mediated neuroinflammation","volume":"983","author":"Li H","year":"2024","unstructured":"Li H, Hu W, Wu Z, Tian B, Ren Y, Zou X. Esketamine improves cognitive function in sepsis-associated encephalopathy by inhibiting microglia-mediated neuroinflammation. Euro J Pharmacol. 2024;983:177014.","journal-title":"Euro J Pharmacol"},{"issue":"43","key":"ref57","doi-asserted-by":"crossref","first-page":"40934","DOI":"10.1021\/acsomega.3c06250","article-title":"Memantine Attenuates Cognitive and Emotional Dysfunction in Mice with Sepsis-Associated Encephalopathy","volume":"8","author":"Zheng X","year":"2023","unstructured":"Zheng X, Li W, Xiang Q, Wang Y, Qu T, Fang W, et al. Memantine Attenuates Cognitive and Emotional Dysfunction in Mice with Sepsis-Associated Encephalopathy. ACS Omega. 2023;8(43):40934\u201343.","journal-title":"ACS Omega"},{"key":"ref58","first-page":"13","article-title":"Activation of \u03b22-Adrenoceptor Attenuates Sepsis-Induced Hippocampus-Dependent Cognitive Impairments by Reversing Neuroinflammation and Synaptic Abnormalities","author":"Zong M-M","year":"2019","unstructured":"Zong M-M, Zhou Z-Q, Ji M-H, Jia M, Tang H, Yang J-J. Activation of \u03b22-Adrenoceptor Attenuates Sepsis-Induced Hippocampus-Dependent Cognitive Impairments by Reversing Neuroinflammation and Synaptic Abnormalities. Front Cell Neurosci. 2019;Volume 13\u20132019.","journal-title":"Front Cell Neurosci"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.bbi.2024.02.005","article-title":"Activating astrocytic \u03b12A adrenoceptors in hippocampus reduces glutamate toxicity to attenuate sepsis-associated encephalopathy in mice","volume":"117","author":"Mei B","year":"2024","unstructured":"Mei B, Xu X, Weng J, Yang Y, Wang P, Qiu G, et al. Activating astrocytic \u03b12A adrenoceptors in hippocampus reduces glutamate toxicity to attenuate sepsis-associated encephalopathy in mice. Brain Behav Immun. 2024;117:376\u201398.","journal-title":"Brain Behav Immun"},{"issue":"3","key":"ref60","doi-asserted-by":"crossref","first-page":"e14655","DOI":"10.1111\/cns.14655","article-title":"Serotonergic neurotransmission mediated cognitive dysfunction in two mouse models of sepsis-associated encephalopathy","volume":"30","author":"Zhang C","year":"2024","unstructured":"Zhang C, Tian F, Peng J, Wang X, Li J, Zhang L, et al. Serotonergic neurotransmission mediated cognitive dysfunction in two mouse models of sepsis-associated encephalopathy. CNS Neurosci Ther. 2024;30(3):e14655.","journal-title":"CNS Neurosci Ther"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"775511","DOI":"10.3389\/fmed.2021.775511","article-title":"Revising Host Phenotypes of Sepsis Using Microbiology","volume":"8","author":"Zhao H","year":"2021","unstructured":"Zhao H, Kennedy JN, Wang S, Brant EB, Bernard GR, DeMerle K, et al. Revising Host Phenotypes of Sepsis Using Microbiology. Front Med (Lausanne). 2021;8:775511.","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"ref62","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1097\/CCM.0000000000004842","article-title":"Sepsis Subclasses: A Framework for Development and Interpretation","volume":"49","author":"DeMerle KM","year":"2021","unstructured":"DeMerle KM, Angus DC, Baillie JK, Brant E, Calfee CS, Carcillo J, et al. Sepsis Subclasses: A Framework for Development and Interpretation. Crit Care Med. 2021;49(5):748\u201359.","journal-title":"Crit Care Med"},{"issue":"20","key":"ref63","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2019.5791","article-title":"Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis","volume":"321","author":"Seymour CW","year":"2019","unstructured":"Seymour CW, Kennedy JN, Wang S, Chang CH, Elliott CF, Xu Z, et al. Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. JAMA. 2019;321(20):2003\u201317.","journal-title":"JAMA"},{"issue":"13","key":"ref64","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.1073\/pnas.0600506103","article-title":"Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia","volume":"103","author":"Pavlov VA","year":"2006","unstructured":"Pavlov VA, Ochani M, Gallowitsch-Puerta M, Ochani K, Huston JM, Czura CJ, et al. Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proc Natl Acad Sci U S A. 2006;103(13):5219\u201323.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000006737","article-title":"Efficacy of Ramelteon, Suvorexant, and Lemborexant for Delirium Prevention in Hospitalized Patients: A Systematic Review and Meta-Analysis","volume":"9900","author":"Oliveira HM","unstructured":"de Oliveira HM, Gallo Ruelas M, Zamora FV, Oliveira de Paula G, Oliveira Fonseca PE, Luiz L et al. Efficacy of Ramelteon, Suvorexant, and Lemborexant for Delirium Prevention in Hospitalized Patients: A Systematic Review and Meta-Analysis. Crit Care Med 9900:10.1097\/CCM.0000000000006737","journal-title":"Crit Care Med"},{"issue":"4","key":"ref66","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/j.1748-1716.2008.01836.x","article-title":"Functions of orexins in peripheral tissues","volume":"192","author":"Heinonen MV","year":"2008","unstructured":"Heinonen MV, Purhonen AK, M\u00e4kel\u00e4 KA, Herzig KH. Functions of orexins in peripheral tissues. Acta Physiol (Oxf). 2008;192(4):471\u201385.","journal-title":"Acta Physiol (Oxf)"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.neuroscience.2014.08.027","article-title":"Distribution of orexin-1 receptor-green fluorescent protein- (OX1-GFP) expressing neurons in the mouse brain stem and pons: Co-localization with tyrosine hydroxylase and neuronal nitric oxide synthase","volume":"278","author":"Darwinkel A","year":"2014","unstructured":"Darwinkel A, Stani\u0107 D, Booth LC, May CN, Lawrence AJ, Yao ST. Distribution of orexin-1 receptor-green fluorescent protein- (OX1-GFP) expressing neurons in the mouse brain stem and pons: Co-localization with tyrosine hydroxylase and neuronal nitric oxide synthase. Neurosci. 2014;278:253\u201364.","journal-title":"Neurosci"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"113201","DOI":"10.1016\/j.bbr.2021.113201","article-title":"Targeting muscarinic receptors to treat schizophrenia","volume":"405","author":"Foster DJ","year":"2021","unstructured":"Foster DJ, Bryant ZK, Conn PJ. Targeting muscarinic receptors to treat schizophrenia. Behav Brain Res. 2021;405:113201.","journal-title":"Behav Brain Res"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/bs.apha.2019.12.003","article-title":"M1 muscarinic acetylcholine receptors: A therapeutic strategy for symptomatic and disease-modifying effects in Alzheimer's disease?","volume":"88","author":"Scarpa M","year":"2020","unstructured":"Scarpa M, Hesse S, Bradley SJ. M1 muscarinic acetylcholine receptors: A therapeutic strategy for symptomatic and disease-modifying effects in Alzheimer's disease? Adv Pharmacol. 2020;88:277\u2013310.","journal-title":"Adv Pharmacol"},{"issue":"3","key":"ref70","first-page":"Cd000207","article-title":"Cholinergic medication for antipsychotic-induced tardive dyskinesia","volume":"3","author":"Tammenmaa-Aho I","year":"2018","unstructured":"Tammenmaa-Aho I, Asher R, Soares-Weiser K, Bergman H. Cholinergic medication for antipsychotic-induced tardive dyskinesia. Cochrane Database Syst Rev. 2018;3(3):Cd000207.","journal-title":"Cochrane Database Syst Rev"},{"key":"ref71","article-title":"Xanomeline-Trospium for Adults with Schizophrenia Experiencing Acute Psychosis: A Systematic Review and Meta-analysis of Safety and Tolerability Outcomes","author":"Kishi T","year":"2025","unstructured":"Kishi T, Citrome L, Sakuma K, Hamanaka S, Nishii Y, Hatano M et al. Xanomeline-Trospium for Adults with Schizophrenia Experiencing Acute Psychosis: A Systematic Review and Meta-analysis of Safety and Tolerability Outcomes. Pharmacopsychiatry. 2025.","journal-title":"Pharmacopsychiatry"},{"issue":"8","key":"ref72","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa2017015","article-title":"Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia","volume":"384","author":"Brannan SK","year":"2021","unstructured":"Brannan SK, Sawchak S, Miller AC, Lieberman JA, Paul SM, Breier A. Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia. New Engl J Med. 2021;384(8):717\u201326.","journal-title":"New Engl J Med"},{"issue":"1","key":"ref73","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41398-022-02254-9","article-title":"Effectiveness of KarXT (xanomeline-trospium) for cognitive impairment in schizophrenia: post hoc analyses from a randomised, double-blind, placebo-controlled phase 2 study","volume":"12","author":"Sauder C","year":"2022","unstructured":"Sauder C, Allen LA, Baker E, Miller AC, Paul SM, Brannan SK. Effectiveness of KarXT (xanomeline-trospium) for cognitive impairment in schizophrenia: post hoc analyses from a randomised, double-blind, placebo-controlled phase 2 study. Transl Psychiatry. 2022;12(1):491.","journal-title":"Transl Psychiatry"},{"issue":"10422","key":"ref74","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0140-6736(23)02190-6","article-title":"Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial","volume":"403","author":"Kaul I","year":"2024","unstructured":"Kaul I, Sawchak S, Correll CU, Kakar R, Breier A, Zhu H, et al. Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline-trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial. Lancet. 2024;403(10422):160\u201370.","journal-title":"Lancet"},{"issue":"8","key":"ref75","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/jamapsychiatry.2024.0785","article-title":"Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial","volume":"81","author":"Kaul I","year":"2024","unstructured":"Kaul I, Sawchak S, Walling DP, Tamminga CA, Breier A, Zhu H, et al. Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia: A Randomized Clinical Trial. JAMA Psychiatry. 2024;81(8):749\u201356.","journal-title":"JAMA Psychiatry"},{"issue":"11","key":"ref76","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/d41573-024-00155-8","article-title":"FDA approves first schizophrenia drug with new mechanism of action since 1950s","volume":"23","author":"Kingwell K","year":"2024","unstructured":"Kingwell K. FDA approves first schizophrenia drug with new mechanism of action since 1950s. Nat Rev Drug Discov. 2024;23(11):803.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"ref77","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/ilar\/ilx007","article-title":"Murine Models of Sepsis and Trauma: Can We Bridge the Gap?","volume":"58","author":"Stortz JA","year":"2017","unstructured":"Stortz JA, Raymond SL, Mira JC, Moldawer LL, Mohr AM, Efron PA. Murine Models of Sepsis and Trauma: Can We Bridge the Gap? ILAR J. 2017;58(1):90\u2013105.","journal-title":"ILAR J"},{"issue":"4","key":"ref78","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ymeth.2005.11.009","article-title":"he repetitive use of samples to measure multiple cytokines: the sequential ELISA","volume":"38","author":"Osuchowski MF","year":"2006","unstructured":"Osuchowski MF, remick DG. he repetitive use of samples to measure multiple cytokines: the sequential ELISA. Methods. 2006;38(4):304\u201311.","journal-title":"Methods"},{"issue":"2","key":"ref79","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/SHK.0000000000001485","article-title":"Use of Organ Dysfunction as a Primary Outcome Variable Following Cecal Ligation and Puncture: Recommendations for Future Studies","volume":"54","author":"Abraham MN","year":"2020","unstructured":"Abraham MN, Kelly AP, Brandwein AB, Fernandes TD, Leisman DE, Taylor MD, et al. Use of Organ Dysfunction as a Primary Outcome Variable Following Cecal Ligation and Puncture: Recommendations for Future Studies. Shock. 2020;54(2):168\u201382.","journal-title":"Shock"},{"issue":"2","key":"ref80","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1037\/bne0000433","article-title":"Dreadds: Use and application in behavioral neuroscience","volume":"135","author":"Smith KS","year":"2021","unstructured":"Smith KS, Bucci DJ, Luikart BW, Mahler SV. Dreadds: Use and application in behavioral neuroscience. Behav Neurosci. 2021;135(2):89\u2013107.","journal-title":"Behav Neurosci"},{"issue":"2","key":"ref81","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/JLB.4HI0921-492R","article-title":"T cell activation and IFN\u03b3 modulate organ dysfunction in LPS-mediated inflammation","volume":"112","author":"Taylor MD","year":"2022","unstructured":"Taylor MD, Fernandes TD, Yaipen O, Higgins CE, Capone CA, Leisman DE, et al. T cell activation and IFN\u03b3 modulate organ dysfunction in LPS-mediated inflammation. J Leukoc Biol. 2022;112(2):221\u201332.","journal-title":"J Leukoc Biol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7329263\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7329263\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T17:39:06Z","timestamp":1758649146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7329263\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,25]]},"references-count":81,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-7329263\/v1","relation":{},"subject":[],"published":{"date-parts":[[2025,8,25]]},"subtype":"preprint"}}